JP Stock MarketDetailed Quotes

4574 Taiko Pharmaceutical

Watchlist
  • 402
  • 00.00%
20min DelayMarket to Open Oct 4 15:00 JST
20.36BMarket Cap-5272P/E (Static)

Taiko Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Taiko Pharmaceutical Q2 2024 Earnings Date

Currency：JPYAug 9, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
1.48B
--
+12.26%
EPS
--
5.82
--
+200.82%
Analyst Rating
No Data

Taiko Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 10, 20242024/Q11.377B / ----
Nov 10, 20232023/Q31.929B / ----
May 12, 20232023/Q11.167B / ----
Nov 11, 20222022/Q31.532B / ----
Aug 12, 20222022/Q21.236B / 1.200B--
DatePeriodRevenue/EstimateEarnings Call
May 10, 20242024/Q11.377B / ----
Nov 10, 20232023/Q31.929B / ----
May 12, 20232023/Q11.167B / ----
Nov 11, 20222022/Q31.532B / ----
Aug 12, 20222022/Q21.236B / 1.200B--

Unlock Free Earnings Estimates

Taiko Pharmaceutical Earnings Reports

  • Taiko Pharmaceutical: Consolidated financial statements for the second quarter (interim period) of the fiscal year ending December 2024 (FY2024).

    Aug 14 23:00 ET

  • Taiko Pharmaceutical: Confirmatory letter.

    Aug 9 02:34 ET

  • Taiko Pharmaceutical: Interim Report - 79th period (January 1, 2024 - December 31, 2024)

    Aug 9 02:33 ET

  • Taiko Pharmaceutical: Announcements of individual stocks regarding the revision of consolidated performance estimates and the restructuring of production system in pharmaceutical business (recognition of impairment losses).

    Aug 9 02:30 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data